Wall Street Zen upgraded shares of F5 (NASDAQ:FFIV – Free Report) from a hold rating to a buy rating in a research note published on Saturday. A number of other equities analysts have also recently weighed in on the stock. Piper Sandler reissued an “overweight” rating and set a $461.00 price target (up from $423.00) […]

Wall Street Zen downgraded shares of Grace Therapeutics (NASDAQ:GRCE – Free Report) from a hold rating to a sell rating in a report released on Saturday morning. GRCE has been the topic of a number of other research reports. TD Cowen cut their target price on Grace Therapeutics from $12.00 to $8.00 and set a […]